Indapamide/nebivololAlternative Names: Nebivolol/indapamide
Latest Information Update: 25 Nov 2015
At a glance
- Originator Cadila Healthcare
- Class Antihypertensives; Benzopyrans; Ethanolamines; Indoles; Ischaemic heart disorder therapies; Sulfonamides
- Mechanism of Action Beta 1 adrenergic receptor antagonists; Thiazide-like diuretics
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase III Hypertension